NASDAQ: VIR
Vir Biotechnology Inc Stock Ownership - Who owns Vir Biotechnology?

Insider buying vs selling

Have Vir Biotechnology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Janet NapolitanoDirector2025-06-023,200$5.05
$16.15kSell
Backer Marianne DeChief Executive Officer2025-04-0379,712$5.95
$474.21kSell
Verneuil Vanina DeEVP and General Counsel2025-02-267,373$9.14
$67.40kSell
George A. ScangosDirector2025-02-2410,056$9.45
$95.06kSell
Verneuil Vanina DeEVP and General Counsel2025-02-245,140$9.45
$48.59kSell
Ann M. HanlyEVP Chief Technology Officer2025-02-2414,168$9.45
$133.93kSell
Brent SabatiniSVP Chief Accounting Officer2025-02-241,562$9.45
$14.77kSell
Backer Marianne DeChief Executive Officer2025-02-2416,122$9.45
$152.40kSell
George A. ScangosDirector2025-02-1810,964$9.81
$107.58kSell
Brent SabatiniSVP Chief Accounting Officer2025-02-131,562$9.15
$14.29kSell

1 of 2

VIR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VIR insiders and whales buy or sell their stock.

VIR Shareholders

What type of owners hold Vir Biotechnology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Svf Endurance Cayman Ltd12.07%16,684,041$87.09MInsider
Sb Investment Advisers Uk Ltd12.07%16,684,041$87.09MInstitution
Alaska Permanent Fund Corp12.06%16,666,668$87.00MInsider
Blackrock Inc11.97%16,541,330$86.35MInstitution
Vanguard Group Inc9.26%12,807,508$66.86MInstitution
State Street Corp4.14%5,727,163$29.90MInstitution
Temasek Holdings Private Ltd3.98%5,499,999$28.71MInsider
Dhabi Investment Authority Abu2.65%3,666,666$19.14MInsider
Melinda Gates Foundation Bill2.01%2,777,777$14.50MInsider
Dimensional Fund Advisors LP1.94%2,684,415$14.01MInstitution

1 of 3

VIR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VIR63.04%36.96%Net SellingNet Selling
SION62.87%37.13%Net Buying
PHAR0.01%0.00%
PHAT66.31%33.69%Net BuyingNet Buying
IMTX75.16%0.00%

Vir Biotechnology Stock Ownership FAQ

Who owns Vir Biotechnology?

Vir Biotechnology (NASDAQ: VIR) is owned by 67.40% institutional shareholders, 39.51% Vir Biotechnology insiders, and 0.00% retail investors. Svf Endurance Cayman Ltd is the largest individual Vir Biotechnology shareholder, owning 16.68M shares representing 12.07% of the company. Svf Endurance Cayman Ltd's Vir Biotechnology shares are currently valued at $87.09M.

If you're new to stock investing, here's how to buy Vir Biotechnology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.